Synapse

← Kwok‐Yung Yuen

Papers by Kwok‐Yung Yuen

Page 4 · newest first

  1. In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19Diagnostics · 2021
  2. Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta VariantVaccines · 2021
  3. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapyChemical Science · 2021
  4. Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta VariantDiagnostics · 2021
  5. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecovirusesEmerging Microbes & Infections · 2021
  6. SPINK6 inhibits human airway serine proteases and restricts influenza virus activationEMBO Molecular Medicine · 2021
  7. Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty VaccinationClinical Infectious Diseases · 2021
  8. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injuryNature Communications · 2021
  9. Emerging SARS-CoV-2 variants expand species tropism to murinesEBioMedicine · 2021
  10. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination2021
  11. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses2021
  12. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters2021
  13. In Silico Structure-Based Design of Antiviral Peptides Targeting the Severe Fever with Thrombocytopenia Syndrome Virus Glycoprotein GnViruses · 2021
  14. SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury2021
  15. Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong KongThe Lancet Regional Health - Western Pacific · 2021
  16. Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination SamplesDiagnostics · 2021
  17. Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamstersCommunications Biology · 2021
  18. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus VaccineClinical Infectious Diseases · 2021
  19. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serumEBioMedicine · 2021
  20. Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse ModelClinical Infectious Diseases · 2021
  21. Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challengesnpj Vaccines · 2021
  22. Adenosine synthase A contributes to recurrent Staphylococcus aureus infection by dampening protective immunityEBioMedicine · 2021
  23. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationClinical Infectious Diseases · 2021
  24. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury2021
  25. To prevent SARS‐CoV‐2 transmission in designated quarantine hotel for travelers: Is the ventilation system a concern?Indoor Air · 2021
  26. Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): What is the implication of hospital infection control?Infection Control and Hospital Epidemiology · 2021
  27. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2Nature Communications · 2021
  28. Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza VirusAdvanced Therapeutics · 2021
  29. Mammalian cells use the autophagy process to restrict avian influenza virus replicationCell Reports · 2021
  30. Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory DysfunctionBrain Sciences · 2021
  31. Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike proteinNature Communications · 2021
  32. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individualsClinical Chemistry and Laboratory Medicine (CCLM) · 2021
  33. Invasive cerebral phaeohyphomycosis in a Chinese boy with CARD9 deficiency and showing unique radiological features, managed with surgical excision and antifungal treatmentInternational Journal of Infectious Diseases · 2021
  34. Nosocomial Outbreak of Coronavirus Disease 2019 by Possible Airborne Transmission Leading to a Superspreading EventClinical Infectious Diseases · 2021
  35. Coronaviruses exploit a host cysteine-aspartic protease for efficient replication2021
  36. Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infectionNature Communications · 2021
  37. Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational studyThe Lancet Regional Health - Western Pacific · 2021
  38. Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2Nature Communications · 2021
  39. Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 Virus Variant With Novel Genomic Architecture in Hong KongClinical Infectious Diseases · 2021
  40. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E GenogroupmSphere · 2021
  41. Human Intestinal Organoids Recapitulate Enteric Infections of Enterovirus and CoronavirusStem Cell Reports · 2021
  42. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster ModelClinical Infectious Diseases · 2021
  43. Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic miceNature Communications · 2021
  44. Host and viral determinants for efficient SARS-CoV-2 infection of the human lungNature Communications · 2021
  45. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemicSHILAP Revista de lepidopterología · 2021
  46. Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patientsSHILAP Revista de lepidopterología · 2021
  47. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infectionEmerging Microbes & Infections · 2021
  48. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamstersEmerging Microbes & Infections · 2021
  49. In silico structure-based discovery of a SARS-CoV-2 main protease inhibitorInternational Journal of Biological Sciences · 2021
  50. Repurposing of Miltefosine as an Adjuvant for Influenza VaccineVaccines · 2020